Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Scientific Reports|April 7, 2017
Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligandsSalvatore Pacifico, Alfonso Carotenuto, Diego Brancaccio, et al.Bioorganic Chemistry|July 22, 2020
Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanesGabriele Murineddu, Battistina Asproni, Paola Corona, et al.International Journal of Molecular Sciences|July 24, 2021
In Vitro and In Vivo Pharmaco-Toxicological Characterization of 1-Cyclohexyl-x-methoxybenzene Derivatives in Mice: Comparison with Tramadol and PCPSabrine Bilel, Micaela Tirri, Raffaella Arfè, et al.International Journal of Molecular Sciences|October 27, 2022
Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP ReceptorsKarol Wtorek, Alessia Ghidini, Luca Gentilucci, et al.Plos One|June 9, 2016
Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)Mark F Bird, Maria Camilla Cerlesi, Mark Brown, et al.The Journal of Pharmacology and Experimental Therapeutics|March 3, 2007
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studiesBarbara Spagnolo, Giacomo Carrà, Martina Fantin, et al.Journal of Medicinal Chemistry|March 18, 2021
Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo ActivityValentina Albanese, Chiara Ruzza, Erika Marzola, et al.British Journal of Pharmacology|August 16, 2025
Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in miceChiara Sturaro, Pietro Pola, Michela Argentieri, et al.Journal of Medicinal Chemistry|November 4, 2025
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric LigandsValentina Albanese, Pietro Pola, Michela Argentieri, et al.British Journal of Pharmacology|November 8, 2005
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803)Valeria Camarda, Martina Spagnol, Wei Song, et al.Pageof 7